PROCTER & GAMBLE HEALTH | BIOCON | PROCTER & GAMBLE HEALTH/ BIOCON |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 34.4 | 19.7 | 174.7% | View Chart |
P/BV | x | 10.5 | 1.8 | 581.9% | View Chart |
Dividend Yield | % | 2.0 | 0.6 | 356.3% |
PROCTER & GAMBLE HEALTH BIOCON |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
BIOCON Mar-23 |
PROCTER & GAMBLE HEALTH/ BIOCON |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 388 | 1,383.6% | |
Low | Rs | 3,883 | 192 | 2,026.6% | |
Sales per share (Unadj.) | Rs | 740.7 | 93.1 | 795.9% | |
Earnings per share (Unadj.) | Rs | 138.2 | 5.4 | 2,581.1% | |
Cash flow per share (Unadj.) | Rs | 155.2 | 14.6 | 1,060.8% | |
Dividends per share (Unadj.) | Rs | 95.00 | 1.50 | 6,333.3% | |
Avg Dividend yield | % | 2.1 | 0.5 | 396.8% | |
Book value per share (Unadj.) | Rs | 447.6 | 146.5 | 305.5% | |
Shares outstanding (eoy) | m | 16.60 | 1,200.60 | 1.4% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 3.1 | 200.6% | |
Avg P/E ratio | x | 33.5 | 54.1 | 61.8% | |
P/CF ratio (eoy) | x | 29.8 | 19.8 | 150.5% | |
Price / Book Value ratio | x | 10.3 | 2.0 | 522.5% | |
Dividend payout | % | 68.7 | 28.0 | 245.4% | |
Avg Mkt Cap | Rs m | 76,761 | 347,814 | 22.1% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 21,810 | 9.5% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 111,742 | 11.0% | |
Other income | Rs m | 184 | 7,681 | 2.4% | |
Total revenues | Rs m | 12,480 | 119,423 | 10.5% | |
Gross profit | Rs m | 3,247 | 16,611 | 19.5% | |
Depreciation | Rs m | 281 | 11,131 | 2.5% | |
Interest | Rs m | 8 | 4,190 | 0.2% | |
Profit before tax | Rs m | 3,142 | 8,971 | 35.0% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | 2,541 | 33.3% | |
Profit after tax | Rs m | 2,295 | 6,430 | 35.7% | |
Gross profit margin | % | 26.4 | 14.9 | 177.6% | |
Effective tax rate | % | 27.0 | 28.3 | 95.2% | |
Net profit margin | % | 18.7 | 5.8 | 324.3% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 123,340 | 9.5% | |
Current liabilities | Rs m | 6,791 | 85,107 | 8.0% | |
Net working cap to sales | % | 40.0 | 34.2 | 117.0% | |
Current ratio | x | 1.7 | 1.4 | 119.0% | |
Inventory Days | Days | 263 | 129 | 203.7% | |
Debtors Days | Days | 343 | 117 | 294.3% | |
Net fixed assets | Rs m | 10,617 | 394,078 | 2.7% | |
Share capital | Rs m | 166 | 6,003 | 2.8% | |
"Free" reserves | Rs m | 7,265 | 169,926 | 4.3% | |
Net worth | Rs m | 7,431 | 175,929 | 4.2% | |
Long term debt | Rs m | 0 | 152,905 | 0.0% | |
Total assets | Rs m | 22,330 | 517,418 | 4.3% | |
Interest coverage | x | 409.1 | 3.1 | 13,022.8% | |
Debt to equity ratio | x | 0 | 0.9 | 0.0% | |
Sales to assets ratio | x | 0.6 | 0.2 | 255.0% | |
Return on assets | % | 10.3 | 2.1 | 502.4% | |
Return on equity | % | 30.9 | 3.7 | 845.0% | |
Return on capital | % | 42.4 | 4.0 | 1,059.1% | |
Exports to sales | % | 0 | 3.1 | 0.0% | |
Imports to sales | % | 13.1 | 6.0 | 219.3% | |
Exports (fob) | Rs m | NA | 3,467 | 0.0% | |
Imports (cif) | Rs m | 1,605 | 6,654 | 24.1% | |
Fx inflow | Rs m | 1,465 | 3,467 | 42.3% | |
Fx outflow | Rs m | 1,605 | 6,654 | 24.1% | |
Net fx | Rs m | -140 | -3,187 | 4.4% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | 18,525 | 12.7% | |
From Investments | Rs m | -215 | -142,818 | 0.2% | |
From Financial Activity | Rs m | -985 | 130,487 | -0.8% | |
Net Cashflow | Rs m | 1,160 | 6,411 | 18.1% |
Indian Promoters | % | 0.0 | 40.4 | - | |
Foreign collaborators | % | 51.8 | 20.3 | 255.5% | |
Indian inst/Mut Fund | % | 20.3 | 21.1 | 96.2% | |
FIIs | % | 7.6 | 6.6 | 116.0% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 39.4 | 122.4% | |
Shareholders | 56,730 | 434,339 | 13.1% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PROCTER & GAMBLE HEALTH With: SUN PHARMA DIVIS LABORATORIES CIPLA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | Biocon | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.69% | 3.04% | 1.18% |
1-Month | -7.59% | -2.42% | -0.75% |
1-Year | -3.15% | 30.66% | 61.82% |
3-Year CAGR | -9.16% | -13.51% | 18.16% |
5-Year CAGR | 5.72% | -2.70% | 19.79% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the Biocon share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of Biocon the stake stands at 60.6%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of Biocon.
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
Biocon paid Rs 1.5, and its dividend payout ratio stood at 28.0%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of Biocon.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.